EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers

Guo-Sheng Hu, Zao-Zao Zheng, Yao-Hui He, Du-Chuang Wang, Rui-Chao Nie, Wen Liu

Molecular & Cellular Proteomics · 2025-03 · 24 (3) · 100919

DOI: 10.1016/j.mcpro.2025.100919 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2025-03. Verfasst von Guo-Sheng Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, China; State Key Laboratory of Cellular Stress…. Hauptthemen laut MEDLINE: Neoplasms, Biomarkers, Tumor, Gene Expression Profiling, Proteome. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Key Technologies Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding dysregulated genes and pathways in cancer is critical for precision oncology. Integrating mass spectrometry-based proteomic data with transcriptomic data presents unique opportunities for systematic analyses of dysregulated genes and pathways in pan-cancer. Here, we compiled a comprehensive set of datasets, encompassing proteomic data from 2404 samples and transcriptomic data from 7752 samples across 13 cancer types. Comparisons between normal or adjacent normal tissues and tumor tissues identified several dysregulated pathways including mRNA splicing, interferon pathway, fatty acid metabolism, and complement coagulation cascade in pan-cancer. Additionally, pan-cancer upregulated and downregulated genes (PCUGs and PCDGs) were also identified. Notably, RRM2 and ADH1B, two genes which belong to PCUGs and PCDGs, respectively, were identified as robust pan-cancer diagnostic biomarkers. TNM stage-based comparisons revealed dysregulated genes and biological pathways involved in cancer progression, among which the dysregulation of complement coagulation cascade and epithelial-mesenchymal transition are frequent in multiple types of cancers. A group of pan-cancer continuously upregulated and downregulated proteins in different tumor stages (PCCUPs and PCCDPs) were identified. We further constructed prognostic risk stratification models for corresponding cancer types based on dysregulated genes, which effectively predict the prognosis for patients with these cancers. Drug prediction based on PCUGs and PCDGs as well as PCCUPs and PCCDPs revealed that small molecule inhibitors targeting CDK, HDAC, MEK, JAK, PI3K, and others might be effective treatments for pan-cancer, thereby supporting drug repurposing. We also developed web tools for cancer diagnosis, pathologic stage assessment, and risk evaluation. Overall, this study highlights the power of combining proteomic and transcriptomic data to identify valuable diagnostic and prognostic markers as well as drug targets and treatments for cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsBiomarkers, TumorGene Expression ProfilingProteomeTranscriptomeProteomicsHumansGene Expression Regulation, NeoplasticPrognosis

Stichwörter der Autor:innen

diagnostic markerdrug targetspan-cancerprognostic markerproteomicstranscriptomics

Substanzen

Biomarkers, TumorProteome

Autor:innen und Institutionen

  • Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou, China; State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Faculty of Medicine and L…
  • State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian, China; Fujian Provincial Key Laboratory of Innovative Drug Ta…

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Key Technologies Research and Development Program
  • National Key Research and Development Program of China
  • Science, Technology and Innovation Commission of Shenzhen Municipality
  • Shenzhen Science and Technology Innovation Program

Zitieren

APA

Hu, G. S., Zheng, Z. Z., He, Y. H., Wang, D. C., Nie, R. C., & Liu, W. (2025). Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers. Molecular & Cellular Proteomics, 24(3), 100919. https://doi.org/10.1016/j.mcpro.2025.100919

Vancouver

Hu GS, Zheng ZZ, He YH, Wang DC, Nie RC, Liu W. Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers. Molecular & Cellular Proteomics. 2025;24(3):100919. doi:10.1016/j.mcpro.2025.100919

BibTeX
@article{Hu2025,
  author = {Hu, Guo-Sheng and Zheng, Zao-Zao and He, Yao-Hui and Wang, Du-Chuang and Nie, Rui-Chao and Liu, Wen},
  title = {Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers},
  journal = {Molecular & Cellular Proteomics},
  year = {2025},
  volume = {24},
  number = {3},
  pages = {100919},
  doi = {10.1016/j.mcpro.2025.100919}
}
Kostenlos starten →